focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
I understand that what SCLP is doing is a protracted process. My gripes are only 1. The BOD needs to recognise their obligation to shareholders. 2. The BOD need to try to run faster and not drop the ball
I understand that what SCLP is doing is a protracted process. My gripes are only 1. The BOD needs to recognise their obligation to shareholders. 2. The BOD need to try to run faster and not drop the ball
when it happens it will be magnificent.
I have no doubt SCLPs extraordinary creations are/will be life saving and our share price will reach pounds rather than pence. Sadly, I am beginning to believe that I will not see it in my lifetime (and I’m healthy and relatively young still !!)
I think there are many of the ‘cheesed off’ view. I think the science, potential and brilliance is pretty unquestionable. What is poor is the company’s lack of ability to draw attention to what it’s doing, inefficiency, and seeming inability to extract value from what it has achieved to date.
The money I have put onto Scancell was not a donation to a university facility but an investment in a quoted company. At some point the BOD needs to recognise that shareholders are part owners of the operation and efforts need to be made to create some sort of value before many throw in the towel.
If our BoD can’t think of a better option perhaps Ebay is the way ahead !
Well TF, I’m probably as stale a bull as you can get in SCLP with a 7 +year old holding and impressive losses. We invest for a reason and can only hope that at some point that a return materialises.
Though full of promise and gallons of jam tomorrow it has , for me, not been the finest investment to date.
What value a company with a suite of cancer busting treatments ?
£40m
£400m
£4bn
?
We are now well on the way to knowing if this is what have. Early trial patients still heathy, years later.
Some very serious upside here as positive news comes in.
In for the ride
So, on that basis, as knowledge of the science spreads and results proving SCLP abilities - in humans- become known we should anticipate an unprecedented skyward run. The truth, in all its glory, will (at least start to) become apparent in the coming 18 - 24 months.
I’m in and buckled
As we are with promising but unproven science and a small trial behind us leaving a number of seriously ill patients surviving years beyond expectations - up to £250m
If science is proven not to work at all - down to £0
If science is proven to significantly improve life expectancy in one or two relatively common cancers, at low cost, with few to no unpleasant side effects £1bn ++
If SCLP science platforms proven and multiple cancers ‘treatable’, future cancer treatment changed forever £ A lot.
Just my guess
Let’s be happy for a better week.
Let’s be realistic we are still in single figure pennies.
Full of admiration for your limitless enthusiasm.
My first purchase was in the mid 30’s several years ago
Still here. Still a believer
Looking forward to results and returns
Relief, I suppose, that a professional investor has belief in the potential of our science to the point of putting up some hard cash. A shame that they are such good negotiators that they managed to get so much for so little.
A lot to look forward to , most of all, hard evidence that Scancell can produce multiple cancer busting products.
Renewed interest in this little company, a massive revaluation of its worth.
Bullish, Bruised and still a Buyer